id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1992-E-0012-0002,FDA,FDA-1992-E-0012,Determination of Regulatory Review Period for Purposes of Patent Extension; Supprelin; Correction,Notice,Correction,1994-05-26T04:00:00Z,1994,5,,,2023-09-25T11:46:30Z,94-9047,0,0,0900006480526109
FDA-1992-E-0012-0003,FDA,FDA-1992-E-0012,"Acknowledgement Letter from FDA Dockets Management Branch to Fitch, Even, Tabin & Flannery",Other,Acknowledgement Letter/Receipt,1994-04-08T04:00:00Z,1994,4,,,2023-09-25T11:57:36Z,,0,0,090000648052610d